SH – Center for iPS Cell Research and Application – Kyoto University

Home 2024

Figure: Generation of engineered heart tissues (Left) and a cardiac organoid (Right) derived from iPSCs. Left: Scale bar: 500 μm Right: White: Troponin T2 (cardiomyocytes), Green: GFP (fibroblasts), Red: Fibronectin, Blue: Nuclei. Scale bar: 50 μm - treatments for cardiac ailments

The role of stem cell-derived tissues in novel treatments for cardiac ailments

July 2, 2024

Curbs on animal testing mean human tissues derived from induced pluripotent stem cells offer a promising platform in discovering novel treatments for cardiac ailments.

Follow Open Access Government

Latest Publication

Open Access Government April 2024

Quick Launch Publication More Details

April 8, 2024

Archives

The role of stem cell-derived tissues in novel treatments for cardiac ailments

Follow Open Access Government

Latest Publication

Open Access Government April 2024